🔗 Visit the ClinicalTrials.gov page for NCT00022451
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting c-Myc, Ras and IGF cascade to treat cancer and vascular disorders. | Cell Cycle | 2006 | 0.94 |
| 2 | Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group. | Pediatr Blood Cancer | 2010 | 0.80 |
| 3 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |